ArticleCancer immunology, immunotherapy : CII1989

Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.

H F Dullens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.